What is the treatment for an allergic reaction in the emergency room (ER)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Treatment of Allergic Reactions in the ER

The first-line treatment for allergic reactions in the emergency room is intramuscular (IM) epinephrine, which should be administered promptly as the cornerstone of management for anaphylaxis. 1

Initial Assessment and Management

Severity Assessment

  • Mild reactions: Localized hives, mild itching, mild swelling
  • Severe reactions/Anaphylaxis: Any of the following:
    • Respiratory symptoms (stridor, wheezing, shortness of breath)
    • Cardiovascular symptoms (hypotension, tachycardia)
    • Widespread urticaria or angioedema
    • GI symptoms (vomiting, diarrhea, abdominal cramps)
    • Altered mental status

Immediate Actions for Anaphylaxis

  1. Administer epinephrine IM into the anterolateral thigh 1

    • Adults and children ≥30 kg: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution)
    • Children <30 kg: 0.01 mg/kg, maximum 0.3 mg
    • May repeat every 5-15 minutes if symptoms persist 1, 2
  2. Position patient appropriately

    • Place in recumbent position with legs elevated if tolerated 1
    • This improves venous return and cardiac output
  3. Call for help/activate emergency response system 1

Secondary Interventions

After epinephrine administration, implement these additional measures:

Airway and Breathing

  • Provide supplemental oxygen if needed 1
  • Monitor oxygen saturation
  • For bronchospasm not responding to epinephrine, administer inhaled albuterol 1

Circulation

  • Establish IV access
  • Administer IV fluids for hypotension (10-20 mL/kg bolus) 1
  • Monitor vital signs every 5-15 minutes until stable

Medications (Adjunctive Therapy)

  • H1 antihistamines (e.g., diphenhydramine 25-50 mg IV/IM/PO) 1, 3

    • Note: These are second-line agents and should not replace epinephrine
    • Only relieve itching and urticaria, not respiratory symptoms or shock
  • H2 antihistamines (e.g., ranitidine)

    • May be used in combination with H1 antihistamines
    • Should not be used without H1 antihistamines 1
  • Corticosteroids (e.g., methylprednisolone 1-2 mg/kg IV)

    • May help prevent biphasic or protracted reactions
    • Slow onset of action; not effective for acute symptoms 1

Special Considerations

Refractory Anaphylaxis

  • If no response to IM epinephrine and fluid resuscitation:
    • Consider IV epinephrine (1:10,000 solution) 1
    • Consider additional vasopressors (e.g., dopamine, norepinephrine) 1, 4
    • For patients on beta-blockers, consider glucagon (1-5 mg IV over 5 minutes, followed by infusion) 1

Monitoring

  • Continue monitoring for at least 4-6 hours after symptom resolution
  • Longer observation may be needed for severe reactions or those requiring multiple doses of epinephrine 5
  • Monitor for biphasic reactions (recurrence of symptoms after initial resolution)

Common Pitfalls to Avoid

  1. Delaying epinephrine administration - This is associated with increased mortality and morbidity 1
  2. Using antihistamines or corticosteroids as first-line treatment - These medications do not treat respiratory or cardiovascular symptoms and have a delayed onset of action 1
  3. Administering epinephrine subcutaneously instead of intramuscularly - IM administration provides more rapid and reliable absorption 1
  4. Discharging patients too early - Patients should be observed for potential biphasic reactions 4
  5. Not prescribing epinephrine auto-injectors at discharge - Patients with anaphylaxis should be prescribed auto-injectors and educated on their use 1

Discharge Planning

  • Prescribe epinephrine auto-injector(s) 1
  • Provide patient education on:
    • Proper use of auto-injector
    • Allergen avoidance
    • Recognition of symptoms
    • When to seek emergency care
  • Refer to an allergist for follow-up and consideration of immunotherapy if appropriate 1
  • Consider multiple epinephrine devices for patients with history of severe anaphylaxis or those who have required multiple doses previously 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anaphylaxis: Emergency Department Treatment.

Emergency medicine clinics of North America, 2022

Research

Contextual community epinephrine prescribing: Is more always better?

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.